Cargando…

Design and Methods of the Validating Injury to the Renal Transplant Using Urinary Signatures (VIRTUUS) Study in Children

Lack of noninvasive diagnostic and prognostic biomarkers to reliably detect early allograft injury poses a major hindrance to long-term allograft survival in pediatric kidney transplant recipients. METHODS. Validating Injury to the Renal Transplant Using Urinary Signatures Children’s Study, a North...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Juhi, Contrepois, Kévin, Snyder, Michael, Grimm, Paul C., Moudgil, Asha, Smith, Jodi M., Bobrowski, Amy E., Verghese, Priya S., Hooper, David, Ingulli, Elizabeth, Lestz, Rachel, Weng, Patricia, Reason, Janaiya L., Blydt-Hansen, Tom D., Suthanthiran, Manikkam, Keating, Brendan, Amaral, Sandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8601357/
https://www.ncbi.nlm.nih.gov/pubmed/34805493
http://dx.doi.org/10.1097/TXD.0000000000001244
_version_ 1784601329315872768
author Kumar, Juhi
Contrepois, Kévin
Snyder, Michael
Grimm, Paul C.
Moudgil, Asha
Smith, Jodi M.
Bobrowski, Amy E.
Verghese, Priya S.
Hooper, David
Ingulli, Elizabeth
Lestz, Rachel
Weng, Patricia
Reason, Janaiya L.
Blydt-Hansen, Tom D.
Suthanthiran, Manikkam
Keating, Brendan
Amaral, Sandra
author_facet Kumar, Juhi
Contrepois, Kévin
Snyder, Michael
Grimm, Paul C.
Moudgil, Asha
Smith, Jodi M.
Bobrowski, Amy E.
Verghese, Priya S.
Hooper, David
Ingulli, Elizabeth
Lestz, Rachel
Weng, Patricia
Reason, Janaiya L.
Blydt-Hansen, Tom D.
Suthanthiran, Manikkam
Keating, Brendan
Amaral, Sandra
author_sort Kumar, Juhi
collection PubMed
description Lack of noninvasive diagnostic and prognostic biomarkers to reliably detect early allograft injury poses a major hindrance to long-term allograft survival in pediatric kidney transplant recipients. METHODS. Validating Injury to the Renal Transplant Using Urinary Signatures Children’s Study, a North American multicenter prospective cohort study of pediatric kidney transplant recipients, aims to validate urinary cell mRNA and metabolite profiles that were diagnostic and prognostic of acute cellular rejection (ACR) and BK virus nephropathy (BKVN) in adult kidney transplant recipients in Clinical Trials in Organ Transplantation-4. Specifically, we are investigating: (1) whether a urinary cell mRNA 3-gene signature (18S-normalized CD3ε, CXCL10 mRNA, and 18S ribosomal RNA) discriminates biopsies with versus without ACR, (2) whether a combined metabolite profile with the 3-gene signature increases sensitivity and specificity of diagnosis and prognostication of ACR, and (3) whether BKV-VP1 mRNA levels in urinary cells are diagnostic of BKVN and prognostic for allograft failure. RESULTS. To date, 204 subjects are enrolled, with 1405 urine samples, including 144 biopsy-associated samples. Among 424 urine samples processed for mRNA, the median A260:280 ratio (RNA purity) was 1.91, comparable with Clinical Trials in Organ Transplantation-4 (median 1.82). The quality control failure rate was 10%. Preliminary results from urine supernatant showed that our metabolomics platform successfully captured a broad array of metabolites. Clustering of pool samples and overlay of samples from various batches demonstrated platform robustness. No study site effect was noted. CONCLUSIONS. Multicenter efforts to ascertain urinary biomarkers in pediatric kidney transplant recipients are feasible with high-quality control. Further study will inform whether these signatures are discriminatory and predictive for rejection and infection.
format Online
Article
Text
id pubmed-8601357
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-86013572021-11-19 Design and Methods of the Validating Injury to the Renal Transplant Using Urinary Signatures (VIRTUUS) Study in Children Kumar, Juhi Contrepois, Kévin Snyder, Michael Grimm, Paul C. Moudgil, Asha Smith, Jodi M. Bobrowski, Amy E. Verghese, Priya S. Hooper, David Ingulli, Elizabeth Lestz, Rachel Weng, Patricia Reason, Janaiya L. Blydt-Hansen, Tom D. Suthanthiran, Manikkam Keating, Brendan Amaral, Sandra Transplant Direct Pediatric Transplantation Lack of noninvasive diagnostic and prognostic biomarkers to reliably detect early allograft injury poses a major hindrance to long-term allograft survival in pediatric kidney transplant recipients. METHODS. Validating Injury to the Renal Transplant Using Urinary Signatures Children’s Study, a North American multicenter prospective cohort study of pediatric kidney transplant recipients, aims to validate urinary cell mRNA and metabolite profiles that were diagnostic and prognostic of acute cellular rejection (ACR) and BK virus nephropathy (BKVN) in adult kidney transplant recipients in Clinical Trials in Organ Transplantation-4. Specifically, we are investigating: (1) whether a urinary cell mRNA 3-gene signature (18S-normalized CD3ε, CXCL10 mRNA, and 18S ribosomal RNA) discriminates biopsies with versus without ACR, (2) whether a combined metabolite profile with the 3-gene signature increases sensitivity and specificity of diagnosis and prognostication of ACR, and (3) whether BKV-VP1 mRNA levels in urinary cells are diagnostic of BKVN and prognostic for allograft failure. RESULTS. To date, 204 subjects are enrolled, with 1405 urine samples, including 144 biopsy-associated samples. Among 424 urine samples processed for mRNA, the median A260:280 ratio (RNA purity) was 1.91, comparable with Clinical Trials in Organ Transplantation-4 (median 1.82). The quality control failure rate was 10%. Preliminary results from urine supernatant showed that our metabolomics platform successfully captured a broad array of metabolites. Clustering of pool samples and overlay of samples from various batches demonstrated platform robustness. No study site effect was noted. CONCLUSIONS. Multicenter efforts to ascertain urinary biomarkers in pediatric kidney transplant recipients are feasible with high-quality control. Further study will inform whether these signatures are discriminatory and predictive for rejection and infection. Lippincott Williams & Wilkins 2021-11-17 /pmc/articles/PMC8601357/ /pubmed/34805493 http://dx.doi.org/10.1097/TXD.0000000000001244 Text en Copyright © 2021 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Pediatric Transplantation
Kumar, Juhi
Contrepois, Kévin
Snyder, Michael
Grimm, Paul C.
Moudgil, Asha
Smith, Jodi M.
Bobrowski, Amy E.
Verghese, Priya S.
Hooper, David
Ingulli, Elizabeth
Lestz, Rachel
Weng, Patricia
Reason, Janaiya L.
Blydt-Hansen, Tom D.
Suthanthiran, Manikkam
Keating, Brendan
Amaral, Sandra
Design and Methods of the Validating Injury to the Renal Transplant Using Urinary Signatures (VIRTUUS) Study in Children
title Design and Methods of the Validating Injury to the Renal Transplant Using Urinary Signatures (VIRTUUS) Study in Children
title_full Design and Methods of the Validating Injury to the Renal Transplant Using Urinary Signatures (VIRTUUS) Study in Children
title_fullStr Design and Methods of the Validating Injury to the Renal Transplant Using Urinary Signatures (VIRTUUS) Study in Children
title_full_unstemmed Design and Methods of the Validating Injury to the Renal Transplant Using Urinary Signatures (VIRTUUS) Study in Children
title_short Design and Methods of the Validating Injury to the Renal Transplant Using Urinary Signatures (VIRTUUS) Study in Children
title_sort design and methods of the validating injury to the renal transplant using urinary signatures (virtuus) study in children
topic Pediatric Transplantation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8601357/
https://www.ncbi.nlm.nih.gov/pubmed/34805493
http://dx.doi.org/10.1097/TXD.0000000000001244
work_keys_str_mv AT kumarjuhi designandmethodsofthevalidatinginjurytotherenaltransplantusingurinarysignaturesvirtuusstudyinchildren
AT contrepoiskevin designandmethodsofthevalidatinginjurytotherenaltransplantusingurinarysignaturesvirtuusstudyinchildren
AT snydermichael designandmethodsofthevalidatinginjurytotherenaltransplantusingurinarysignaturesvirtuusstudyinchildren
AT grimmpaulc designandmethodsofthevalidatinginjurytotherenaltransplantusingurinarysignaturesvirtuusstudyinchildren
AT moudgilasha designandmethodsofthevalidatinginjurytotherenaltransplantusingurinarysignaturesvirtuusstudyinchildren
AT smithjodim designandmethodsofthevalidatinginjurytotherenaltransplantusingurinarysignaturesvirtuusstudyinchildren
AT bobrowskiamye designandmethodsofthevalidatinginjurytotherenaltransplantusingurinarysignaturesvirtuusstudyinchildren
AT verghesepriyas designandmethodsofthevalidatinginjurytotherenaltransplantusingurinarysignaturesvirtuusstudyinchildren
AT hooperdavid designandmethodsofthevalidatinginjurytotherenaltransplantusingurinarysignaturesvirtuusstudyinchildren
AT ingullielizabeth designandmethodsofthevalidatinginjurytotherenaltransplantusingurinarysignaturesvirtuusstudyinchildren
AT lestzrachel designandmethodsofthevalidatinginjurytotherenaltransplantusingurinarysignaturesvirtuusstudyinchildren
AT wengpatricia designandmethodsofthevalidatinginjurytotherenaltransplantusingurinarysignaturesvirtuusstudyinchildren
AT reasonjanaiyal designandmethodsofthevalidatinginjurytotherenaltransplantusingurinarysignaturesvirtuusstudyinchildren
AT blydthansentomd designandmethodsofthevalidatinginjurytotherenaltransplantusingurinarysignaturesvirtuusstudyinchildren
AT suthanthiranmanikkam designandmethodsofthevalidatinginjurytotherenaltransplantusingurinarysignaturesvirtuusstudyinchildren
AT keatingbrendan designandmethodsofthevalidatinginjurytotherenaltransplantusingurinarysignaturesvirtuusstudyinchildren
AT amaralsandra designandmethodsofthevalidatinginjurytotherenaltransplantusingurinarysignaturesvirtuusstudyinchildren